** Medical gloves and surgical gowns maker Ansell ANN.AX falls 1.3% to A$29.33
** Morgan Stanley factors in downside risk due to U.S. tariffs, despite ANN expecting to offset impacts through pricing
** Lowers PT to A$33.40 from A$37.20; retains 'equal-weight'
** Trims revenue growth for co's Industrial and Healthcare units, citing volume risk given slowing macroeconomic growth
** Cuts EPS forecast by 9% in FY26 and 11% in FY27; both below Visible Alpha consensus
** YTD, ANN down ~13%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。